Ku ya 9 Gashyantare 2026, urubuga rwemewe rw'Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) rwatangaje ko ZL-1310 yo guterwa inshinge, agace gashya ka DLL3-targeting antibody-drug conjugate (ADC), gateganijwe guhabwa icyitegererezo cyo kuvura indwara.
Nk'umwe mu bagize ishami ry’ubuvuzi ry’ibitaro bya kaminuza ya Peking bivura kanseri ndetse n’ibitaro byihariye bya kanseri bya Beijing, ishami mpuzamahanga ry’ibitaro bya Beijing mu karere k’Amajyepfo rikoresha urubuga rukomeye rwo gusuzuma no kuvura indwara zitandukanye kugira ngo rihuze vuba ubwo buryo bwo kuvura bugezweho ku isi muri gahunda zo kuvura abarwayi mpuzamahanga. Niba wowe cyangwa uwo ukunda muhanganye n’ibibazo byo kuvura kanseri y’ibihaha mu buryo bwa kabiri cyangwa ubundi, nyamuneka soma witonze amakuru ari hepfo hanyuma uduhamagare vuba.
Hamagara Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing Region South Region ubu ngubu:
- Terefone: 400-880-3716
- Indangamuntu ya WeChat: 17801183037
- Email ①: 100085_010@163.com
- Email ②: myimmnet@163.com
**Amakuru Afatika: Kugeza kuri 86% by'imikorere myiza ku barwayi bafite Metastases zo mu bwonko**
Mu nama ngarukamwaka y’Umuryango w’Abanyamerika wita ku ndwara za kanseri (ASCO) yo mu 2025, hagaragajwe amakuru y’ubushakashatsi ku rwego rw’isi ku cyiciro cya 1a/1b ku ndwara za ZL-1310.
Ku barwayi bavuwe mbere (ubuvuzi bwa kabiri):
- Igipimo cy’ubutabazi bw’ibanze (uORR) kitaremezwa cyageze kuri 67%, aho igipimo cyo kurwanya indwara (DCR) cya 97%.
- Mu itsinda ry’ibipimo by’umubiri byiza (1.6 mg/kg): Igipimo cy’ingaruka ku ntego (ORR) cyazamutse kigera kuri 79%, aho igipimo cyo kurwanya indwara (DCR) cya 100%.
- Ibi bivuze ko: Hafi abarwayi 10 bose bahawe iki gipimo bashoboye kugabanya ikibyimba, kandi abarwayi bagera kuri 8 bagabanutse cyane ikibyimba.
Ku barwayi bagorwa cyane n'indwara ya metastases mu bwonko:
- Abarwayi bafite indwara ya metastases mu bwonko bw’ibanze: Igipimo cy’ingaruka ku bwonko (ORR) cyari 68%.
- Abarwayi batigeze bahabwa radiyo yo mu mutwe: Igipimo cyo gusubiza neza mu mutwe (ORR) cyari hejuru cyane kigera kuri 86%!
Aya makuru ni ay’ingenzi cyane. Imiti gakondo ya chimiotherapie iragorwa no kwinjira mu ruzitiro rw’amaraso n’ubwonko, nyamara ZL-1310 igaragaza imikorere ikomeye yo kurwanya ikibyimba mu bwonko. Ku barwayi mpuzamahanga bahangayikishijwe n’ingaruka mbi zo kuvura hakoreshejwe imirasire mu bwonko bwose, ibi bigaragaza icyizere gikomeye cyo “kwirinda imirasire y’ubwonko.”
**Urugero rw'Umutekano:** Mu itsinda rya dose iri munsi ya 2.0 mg/kg, umubare w'ingaruka mbi zijyanye n'ubuvuzi (TRAEs) zo mu cyiciro cya 3 cyangwa hejuru wari 6% gusa, nta ndwara y'ibihaha ijyanye n'ubuvuzi (ILD) cyangwa ihagarikwa ry'ubuvuzi ryagaragaye.
—
**III. Kuki wahitamo Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo?**
Ku barwayi mpuzamahanga, kubona uburyo bushya bwo kuvura ntabwo ari ukureba gusa "niba umuti uhari," ahubwo ni no kugena gahunda ijyanye n'"abashobora kuwukoresha, uko uwukoresha, n'abashobora gucunga ingaruka mbi."
Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing ritanga isuzumabumenyi riteganya gukorwa no gucunga ubuvuzi bugezweho nka ZL-1310 ku barwayi babishoboye. Waba ukomoka mu majyepfo y’uburasirazuba bwa Aziya, mu Burasirazuba bwo Hagati, mu Burayi, cyangwa muri Amerika, dufite inzira mpuzamahanga y’ubuvuzi ihamye.
Dutanga serivisi zuzuye kuva ku nama mbere yo kujya mu bitaro, guhindura mu ndimi zitandukanye, amabaruwa ya viza yo kwa muganga, kugeza ku gukurikirana abasubira mu buzima busanzwe. Kubahiriza cyane politiki ya "umuganga umwe, umurwayi umwe, icyumba kimwe" bituma ubuzima bwite bwawe n'icyubahiro cyawe byubahwa byuzuye, ndetse no mu gihugu cy'amahanga.
Kugeza ubu, ZL-1310 yahawe izina ry’umuti w’imfubyi n’izina ry’umuti wihuse na FDA yo muri Amerika. Gahunda yayo yo gushyirwa mu cyiciro cy’imiti ikoreshwa mu Bushinwa izihutisha cyane uburyo bwo kuyikoresha mu Bushinwa.
Ntukareke ngo inzitizi z'ururimi, amakuru adafite aho ahuriye n'ibiza, cyangwa uburyo bugoye bwo kuvura bugubuze kubona ubuvuzi buhanitse. Ishami ry'Ibitaro Mpuzamahanga bya Beijing Region South Oncology Hospital ryashyizeho inzira y'ibidukikije ku barwayi mpuzamahanga.
Fata terefone cyangwa uduhamagare ukoresheje WeChat cyangwa imeri kugira ngo usangize ikibazo cyawe. Abajyanama bacu b'abaganga bazagukorera isuzuma ry'ibanze mu masaha 24.
- Terefone (inama y'amasaha 24): 400-880-3716
- WeChat (itumanaho ryihuse): 17801183037 (ishyigikira Icyongereza n'Igishinwa)
- Imeri (ku nyandiko z'ubuvuzi):
- 100085_010@163.com
- myimmnet@163.com
Igihe cyo kohereza: 12 Gashyantare 2026